EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant Acinetobacter baumannii infections

Defeng Liu, Kexin Zhang, Di Li, Qingqing Du, Yan Li, Jing Wang, Weiwei Jiang, Yan Qian

Frontiers in Cellular and Infection Microbiology · 03.02.2026 · 16

DOI: 10.3389/fcimb.2026.1760018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 03.02.2026. Verfasst von Defeng Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Phage Therapy, Bacteriophages. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The growing global threat of multidrug-resistant Acinetobacter baumannii (MDR-AB) infections highlights an urgent need for novel and effective therapeutic strategies. Phage therapy has emerged as a promising alternative to conventional antibiotics. This study aimed to isolate and comprehensively characterize a novel lytic bacteriophage (phage), designated AbpL, and evaluate its therapeutic potential against MDR-AB.

Methods

AbpL was isolated from sewage samples and characterized in terms of its morphology, growth characteristics, stability, and genome. Comparative genomic classification analysis was also conducted on it. In vitro efficacy was evaluated through time-kill assays and biofilm disruption experiments. To assess in vivo therapeutic potential, a murine model of lethal A. baumannii -induced sepsis was employed, with outcomes including survival rates, bacterial burden, serum levels of inflammatory cytokines, and histopathological evaluation.

Results

AbpL is classified as a member of the genus Friunavirus , subfamily Beijerinckvirinae , family Autoscriptoviridae , order Autographivirales , and class Caudoviricetes . It exhibited an icosahedral head and a short non-contractile tail, and demonstrated a short latent period, a high burst size, and strong stability across a broad range of environmental conditions. AbpL showed lytic activity against 52% of clinical MDR-AB isolates and effectively disrupted pre-existing biofilms. In the murine sepsis model, a single intraperitoneal administration (multiplicity of infection = 10) conferred 100% survival, significantly reduced bacterial loads in the liver and kidneys, and attenuated systemic inflammation compared to treatment with polymyxin B. Histopathological analyses further confirmed the protective effects of AbpL and its favorable safety profile.

Discussion

Owing to its strong lytic activity, environmental stability, and robust in vitro and in vivo efficacy, AbpL represents a highly promising candidate for the treatment of MDR-AB infections. Furthermore, its unique 400-bp terminal redundancy may serve as a valuable platform for future engineering via synthetic biology approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsPhage TherapyBacteriophagesGenome, ViralAnimalsDisease Models, AnimalMiceDrug Resistance, Multiple, BacterialBiofilmsSepsisSewageSurvival AnalysisCytokinesHumansAnti-Bacterial AgentsBacterial Load

Stichwörter der Autor:innen

Acinetobacter baumanniibacteriophage AbpLmultidrug-resistant infectionsphage therapyterminal redundancy

Substanzen

SewageCytokinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Immunology Research Center, Medical Research Institute, Southwest University, Chongqing, China.
  • Department of Microbiology, College of Basic Medical Sciences, Army Medical University, Key Laboratory of Microbial Engineering Under the Educational Committee in Chongqing, Chongqing, China.

Zitieren

APA

Liu, D., Zhang, K., Li, D., Du, Q., Li, Y., Wang, J., Jiang, W., & Qian, Y. (2026). Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant Acinetobacter baumannii infections. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1760018

Vancouver

Liu D, Zhang K, Li D, Du Q, Li Y, Wang J, et al. Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant Acinetobacter baumannii infections. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1760018

BibTeX
@article{Liu2026,
  author = {Liu, Defeng and Zhang, Kexin and Li, Di and Du, Qingqing and Li, Yan and Wang, Jing and Jiang, Weiwei and Qian, Yan},
  title = {Characterization of phage AbpL with a terminally redundant genome and its therapeutic potential against drug-resistant Acinetobacter baumannii infections},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1760018}
}
Kostenlos starten →